Aditxt子公司Pearsanta启动首个人体研究的招募,研究针对影响全球1.9亿女性的子宫内膜异位症的血液检测,全球市场规模达14.5亿美元

美股速递
Oct 27

Aditxt子公司Pearsanta启动首个人体研究的招募,研究针对影响全球1.9亿女性的子宫内膜异位症的血液检测,全球市场规模达14.5亿美元。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10